0000886163-21-000027.txt : 20210205
0000886163-21-000027.hdr.sgml : 20210205
20210205170202
ACCESSION NUMBER: 0000886163-21-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210205
DATE AS OF CHANGE: 20210205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Korenberg Matthew E
CENTRAL INDEX KEY: 0001649903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 21596953
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-02-03
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001649903
Korenberg Matthew E
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
0
1
0
0
EVP,Finance & Strategy and CFO
Common Stock
2021-02-03
4
A
0
10819
0.0
A
41752
D
Employee Stock Option (right to buy)
177.5
2021-02-03
4
A
0
11591
0.0
A
2031-02-03
Common Stock
11591
11591
D
Grant to reporting person of options to purchase shares of common stock ("Option Shares"), exerciseable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/03/2021.
By: Charles S. Berkman For: Matthew E. Korenberg
2021-02-05